Keay Nakae
Stock Analyst at Chardan Capital
(3.60)
# 788
Out of 4,910 analysts
234
Total ratings
33.19%
Success rate
11.08%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COYA Coya Therapeutics | Maintains: Buy | $14 | $6.72 | +108.33% | 19 | Jul 1, 2025 | |
| IBIO iBio, Inc. | Maintains: Buy | $5 | $0.74 | +576.04% | 5 | Jun 25, 2025 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $60 | $46.41 | +29.28% | 1 | Jun 23, 2025 | |
| DYN Dyne Therapeutics | Maintains: Buy | $50 | $9.24 | +441.13% | 12 | Jun 17, 2025 | |
| SLN Silence Therapeutics | Maintains: Buy | $35 | $6.28 | +457.32% | 12 | Jun 13, 2025 | |
| RNA Avidity Biosciences | Maintains: Buy | $65 → $75 | $33.21 | +125.84% | 17 | Jun 9, 2025 | |
| SABS SAB Biotherapeutics | Maintains: Buy | $20 | $2.60 | +669.23% | 15 | May 15, 2025 | |
| OBIO Orchestra BioMed Holdings | Maintains: Buy | $20 | $3.22 | +521.12% | 10 | May 13, 2025 | |
| KRRO Korro Bio | Maintains: Buy | $25 | $15.90 | +57.23% | 2 | May 13, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $60 | $16.26 | +269.00% | 19 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $1.25 → $6 | $13.40 | -55.22% | 10 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $325 | $328.00 | -0.91% | 13 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 | $4.22 | +373.93% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $1.68 | +257.14% | 7 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 | $3.24 | +54.32% | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $2.5 | $2.93 | -14.68% | 6 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $2.26 | +77.38% | 14 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $0.92 | +774.13% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.66 | - | 5 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $8 → $6 | $16.98 | -64.66% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $20 | $0.44 | +4,466.21% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $55 | $7.47 | +636.28% | 10 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.25 → $10 | $8.11 | +23.30% | 5 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $100 → $88 | $10.69 | +718.52% | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $0.7 → $13 | $1.12 | +1,060.71% | 3 | Feb 9, 2021 |
Coya Therapeutics
Jul 1, 2025
Maintains: Buy
Price Target: $14
Current: $6.72
Upside: +108.33%
iBio, Inc.
Jun 25, 2025
Maintains: Buy
Price Target: $5
Current: $0.74
Upside: +576.04%
Monopar Therapeutics
Jun 23, 2025
Initiates: Buy
Price Target: $60
Current: $46.41
Upside: +29.28%
Dyne Therapeutics
Jun 17, 2025
Maintains: Buy
Price Target: $50
Current: $9.24
Upside: +441.13%
Silence Therapeutics
Jun 13, 2025
Maintains: Buy
Price Target: $35
Current: $6.28
Upside: +457.32%
Avidity Biosciences
Jun 9, 2025
Maintains: Buy
Price Target: $65 → $75
Current: $33.21
Upside: +125.84%
SAB Biotherapeutics
May 15, 2025
Maintains: Buy
Price Target: $20
Current: $2.60
Upside: +669.23%
Orchestra BioMed Holdings
May 13, 2025
Maintains: Buy
Price Target: $20
Current: $3.22
Upside: +521.12%
Korro Bio
May 13, 2025
Maintains: Buy
Price Target: $25
Current: $15.90
Upside: +57.23%
Arrowhead Pharmaceuticals
May 13, 2025
Maintains: Buy
Price Target: $60
Current: $16.26
Upside: +269.00%
May 8, 2025
Downgrades: Neutral
Price Target: $1.25 → $6
Current: $13.40
Upside: -55.22%
May 2, 2025
Maintains: Buy
Price Target: $300 → $325
Current: $328.00
Upside: -0.91%
Apr 7, 2025
Maintains: Buy
Price Target: $20
Current: $4.22
Upside: +373.93%
Mar 28, 2025
Maintains: Buy
Price Target: $6
Current: $1.68
Upside: +257.14%
Mar 28, 2025
Maintains: Buy
Price Target: $5
Current: $3.24
Upside: +54.32%
Mar 27, 2025
Maintains: Neutral
Price Target: $2.5
Current: $2.93
Upside: -14.68%
Mar 14, 2025
Maintains: Buy
Price Target: $4
Current: $2.26
Upside: +77.38%
Nov 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $0.92
Upside: +774.13%
Feb 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.66
Upside: -
Aug 4, 2023
Maintains: Sell
Price Target: $8 → $6
Current: $16.98
Upside: -64.66%
Nov 10, 2022
Maintains: Buy
Price Target: $60 → $20
Current: $0.44
Upside: +4,466.21%
Nov 9, 2022
Maintains: Buy
Price Target: $65 → $55
Current: $7.47
Upside: +636.28%
Aug 16, 2022
Maintains: Neutral
Price Target: $1.25 → $10
Current: $8.11
Upside: +23.30%
Sep 20, 2021
Upgrades: Neutral
Price Target: $100 → $88
Current: $10.69
Upside: +718.52%
Feb 9, 2021
Downgrades: Neutral
Price Target: $0.7 → $13
Current: $1.12
Upside: +1,060.71%